Impact of Fever Prevention in Brain Injured Patients (INTREPID)
Primary Objective
Evaluate the Arctic Sun Cooling device for fever prevention to standard of care measures for controlling fever in the ICU
Description
Patients randomized to the fever prevention group will have ArcticGel Pads placed on their body. These will be connected to the Arctic Sun System. The system will be programmed to keep the patient's body temperature at 98.6. Treatment will last for 14 days or until ready to be discharged from the ICU. Standard of care patients will receive standard medical care as prescribed by the medical team.
Details
Locations
University of Colorado Hospital
Principal Investigator
Luis Cava Prado
Study ID
Protocol Number: 18-0548
More information available at ClinicalTrials.gov: NCT02996266
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers